Skip to main content
SpringerLink
Log in

Report of the 12th Sphingolipid Club Meeting, Trabia, Italy (Sept. 7–10, 2017)

  • Review
  • Published:
Naunyn-Schmiedeberg's Archives of Pharmacology Aims and scope Submit manuscript

Abstract

We present here a report of the 12th Sphingolipid Club Meeting held in Trabia, Italy, on September 7–10, 2017. The meeting accounted for the presence of 120 young and senior scientists, coming from both European and overseas countries, interested in the sphingolipid field. The scientific program consisted in a total of 41 oral and 26 poster presentations. The participants contributed actively with formal discussions and informal exchange of views all along the meeting. The original results presented confirm the importance of sphingolipid in both physiological and pathological situations, and offer a promising platform to suggest innovative therapeutic strategies for different diseases.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Di Pardo A, Amico E, Basit A, Armirotti A, Joshi P, Neely DM, Vuono R, Castaldo S, Digilio AF, Scalabrì F, Pepe G, Elifani F, Madonna M, Jeong SK, Park BM, D’Esposito M, Bowman AB, Barker RA, Maglione V (2017) Defective sphingosine-1-phosphate metabolism is a druggable target in Huntington’s disease. Sci Rep 7(1):5280. https://doi.org/10.1038/s41598-017-05709-y

    Article  PubMed  PubMed Central  Google Scholar 

  • Garcia-Ruiz C, Mato JM, Vance D, Kaplowitz N, Fernández-Checa JC (2015) Acid sphingomyelinase-ceramide system in steatohepatitis: a novel target regulating multiple pathways. J Hepatol 62(1):219–233. https://doi.org/10.1016/j.jhep.2014.09.023

    Article  CAS  PubMed  Google Scholar 

  • Hannun YA, Obeid LM (2017) Sphingolipids and their metabolism in physiology and disease. Nat Rev Mol Cell Biol. https://doi.org/10.1038/nrm.2017.107

  • Hemdan NY, Weigel C, Reimann CM, Gräler MH (2016) Modulating sphingosine 1-phosphate signaling with DOP or FTY720 alleviates vascular and immune defects in mouse sepsis. Eur J Immunol 46(12):2767–2777. https://doi.org/10.1002/eji.201646417

    Article  CAS  PubMed  Google Scholar 

  • Makino A, Abe M, Ishitsuka R, Murate M, Kishimoto T, Sakai S, Hullin-Matsuda F, Shimada Y, Inaba T, Miyatake H, Tanaka H, Kurahashi A, Pack CG, Kasai RS, Kubo S, Schieber NL, Dohmae N, Tochio N, Hagiwara K, Sasaki Y, Aida Y, Fujimori F, Kigawa T, Nishibori K, Parton RG, Kusumi A, Sako Y, Anderluh G, Yamashita M, Kobayashi T, Greimel P, Kobayashi T (2017) A novel sphingomyelin/cholesterol domain-specific probe reveals the dynamics of the membrane domains during virus release and in Niemann-Pick type C. FASEB J 31(4):1301–1322. https://doi.org/10.1096/fj.201500075R

    Article  CAS  PubMed  Google Scholar 

  • Mitroi DN, Karunakaran I, Gräler M, Saba JD, Ehninger D, Ledesma MD, van Echten-Deckert G (2017) SGPL1 (sphingosine phosphate lyase 1) modulates neuronal autophagy via phosphatidylethanolamine production. Autophagy 13(5):885–899. https://doi.org/10.1080/15548627.2017.1291471

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Müller CP, Kalinichenko LS, Tiesel J, Witt M, Stöckl T, Sprenger E, Fuchser J, Beckmann J, Praetner M, Huber SE, Amato D, Mühle C, Büttner C, Ekici AB, Smaga I, Pomierny-Chamiolo L, Pomierny B, Filip M, Eulenburg V, Gulbins E, Lourdusamy A, Reichel M, Kornhuber J (2017) Paradoxical antidepressant effects of alcohol are related to acid sphingomyelinase and its control of sphingolipid homeostasis. Acta Neuropathol 133(3):463–483. https://doi.org/10.1007/s00401-016-1658-6

    Article  PubMed  Google Scholar 

  • Newton J, Lima S, Maceyka M, Spiegel S (2015) Revisiting the sphingolipid rheostat: evolving concepts in cancer therapy. Exp Cell Res 333(2):195–200. https://doi.org/10.1016/j.yexcr.2015.02.025

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Ogretmen B (2017) Sphingolipid metabolism in cancer signalling and therapy. Nat Rev Cancer. https://doi.org/10.1038/nrc.2017.96

  • Pérez-Cañamás A, Benvegnù S, Rueda CB, Rábano A, Satrústegui J, Ledesma MD (2017) Sphingomyelin-induced inhibition of the plasma membrane calcium ATPase causes neurodegeneration in type A Niemann-Pick disease. Mol Psychiatry 22(5):711–723. https://doi.org/10.1038/mp.2016.148

    Article  PubMed  Google Scholar 

  • Peters F, Vorhagen S, Brodesser S, Jakobshagen K, Brüning JC, Niessen CM, Krönke M (2015) Ceramide synthase 4 regulates stem cell homeostasis and hair follicle cycling. J Invest Dermatol 135(6):1501–1509. https://doi.org/10.1038/jid.2015.60

    Article  CAS  PubMed  Google Scholar 

  • Pinkert T, Furkert D, Korte T, Herrmann A, Arenz C (2017) Amplification of a FRET probe by lipid-water partition for the detection of acid sphingomyelinase in live cells. Angew Chem Int Ed Engl 56(10):2790–2794. https://doi.org/10.1002/anie.201611706

    Article  CAS  PubMed  Google Scholar 

  • Raj S, Nazemidashtarjandi S, Kim J, Joffe L, Zhang X, Singh A, Mor V, Desmarini D, Djordjevic J, Raleigh DP, Rodrigues ML, London E, del Poeta M, Farnoud AM (2017) Changes in glucosylceramide structure affect virulence and membrane biophysical properties of Cryptococcus neoformans. Biochim Biophys Acta 1859(11):2224–2233. https://doi.org/10.1016/j.bbamem.2017.08.017

    Article  CAS  PubMed  Google Scholar 

  • Schwalm S, Beyer S, Frey H, Haceni R, Grammatikos G, Thomas D, Geisslinger G, Schaefer L, Huwiler A, Pfeilschifter J (2017) Sphingosine kinase-2 deficiency ameliorates kidney fibrosis by up-regulating Smad7 in a mouse model of unilateral ureteral obstruction. Am J Pathol 187(11):2413–2429. https://doi.org/10.1016/j.ajpath.2017.06.017

    Article  CAS  PubMed  Google Scholar 

  • Vanier MT, Caillaud C, Levade T (2016) Disorders of sphingolipid synthesis, sphingolipidoses, Niemann-Pick disease type C and neuronal ceroid-lipofuscinoses. In: Saudubray JM, Baumgartner MR, Walter JH (eds) Inborn metabolic diseases: diagnosis and treatment, 6th edn. Springer, pp 551–575. https://doi.org/10.1007/978-3-662-49771-5_38

Download references

Author information

Authors and Affiliations

  1. INSERM U1037, CRCT (Cancer Research Center of Toulouse) and Laboratoire de Biochimie Métabolique, Institut Fédératif de Biologie, CHU Purpan, Toulouse, France

    Thierry Levade

  2. Department of Health Sciences, Via A. Di Rudinì, 8, 20142, University of Milan, Milan, Italy

    Riccardo Ghidoni

Authors
  1. Thierry Levade
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Riccardo Ghidoni
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Riccardo Ghidoni.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Levade, T., Ghidoni, R. Report of the 12th Sphingolipid Club Meeting, Trabia, Italy (Sept. 7–10, 2017). Naunyn-Schmiedeberg's Arch Pharmacol 391, 111–113 (2018). https://doi.org/10.1007/s00210-017-1452-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00210-017-1452-6

Keywords

Search

Navigation